Get started
CVS HEALTH CORPORATIONCVS HEALTH CORPORATIONCVS HEALTH CORPORATION

CVS HEALTH CORPORATION

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Forecast Seasonals Bonds

CVS trade ideas

CVS price target $72 by 11/06 earningsIf you didn't get a chance to get a position in CVS the past week, you may have a brief opportunity to still get an entry price a hair under $60, thanks to Friday's (10/9) brief pullback. My price target for CVS is $72 by 11/06 earnings. I've said it before, but let me re-iterate, CVS is a value stock with very low risk at this current entry price under $60 (10/09 close $59.40). If you want to balance your trading portfolio forward looking for the rest of the year CVS is definitely the stock to consider. Compared to other competitors in the industry, CVS current valuation gives you a great chance to capitalize on it's impending upward momentum heading into Nov 6 earnings & the winter flu season. Comparisons of CVS to Industry are as follows: P/E 9.43 vs 20.15 : P/S .29 vs 8.85 : P/B 1.14 vs 5.97 as you can see CVS truly is a value play. Good luck and happy trading friends...
NYSE:CVSLong
by Options360
Bottom Fishing Falling WedgeThe Falling Wedge is a bullish pattern that begins wide at the top and contracts as prices move lower. This price action forms a cone that slopes down as the reaction highs and reaction lows converge. In contrast to symmetrical triangles, which have no definitive slope and no bias, falling wedges definitely slope down and have a bullish bias. However, this bullish bias cannot be realized until a resistance breakout occurs. A Falling Wedge fit into a reversal pattern at the bottom, but can also fit into the continuation category. As a continuation pattern, the falling wedge will still slope down, but the slope will be against the prevailing uptrend. As a reversal pattern, the falling wedge slopes down and with the prevailing trend. Regardless of the type (reversal or continuation), falling wedges are regarded as bullish patterns. This could fall further but long term support not far below price Not a recommendation
NYSE:CVS
by lauralea
CVS double bottom bullish reversalGet ready for a transition into value over the next 2 weeks. The confirmation for this breakout is a close above the upper trend line of the double bottom (59.24), with above average volume (50ML). Regardless of the exact day to enter this week of 9/28, current entry point ($57.32 9/25 close) is fantastic with little historical risk on the down side below $60 anyhow. Once this bullish pattern is confirmed CVS will at least hit $70 by 11/20/2020, historically CVS gains +-20% from the end of September to the end of November. CVS fundamentals are impeccable: book value = $110B vs $75B = market cap, P/E 9, EPS 2.26, $15B cash on hand. CVS is the largest pharmacy in the US. Seventy percent of the U.S. population lives within three minutes of a CVS store. CVS fair value is $92 updated on August 9th by Morningstar. For an options play I would pile up the November 20th Calls while they're still on discount. Good luck and happy trading friends.
NYSE:CVSLong
by Options360
17
CVS wedges (falling) bullish from 9/28 to 11/20Get ready for a transition into value over the next 2 weeks. The confirmation for this pattern is a close above the upper descending trendline on above average daily volume (10M). Regardless of the exact day to enter this week 9/28, current entry point ($57.32 9/25 close) is fantastic with little historical risk on the down side below $60 anyhow. Once this bullish pattern of wedges falling is confirmed CVS will at least hit $70 by 11/20/2020, historically CVS gains +-20% from the end of September to the end of November. CVS fundamentals are impeccable: book value = $110B vs $75B = market cap, P/E 9, EPS 2.26, $15B cash on hand. CVS is the largest pharmacy in the US. Seventy percent of the U.S. population lives within three minutes of a CVS store. CVS fair value is $92 updated on August 9th by Morningstar.
NYSE:CVSLong
by Options360
Buying opportunity in CVS after Walgreens earnings bombCVS is pulling back in sympathy with Walgreens after WBA earnings were a dud. However, the adverse impact on Walgreens sales was "almost entirely from the company's non-U.S. businesses," according to the company's report. CVS operates almost exclusively in the United States, with 9,750 US locations and just 150 internationally. This suggests that CVS should be relatively insulated from the fall-off in international demand that Walgreens saw. CVS is in almost every way a better company than Walgreens. It has better analyst ratings, better financial health, and a much better valuation in terms of PEG ratio. Its dividend yield and dividend growth are lower, but its growth plan has been more aggressive, with the rollout of HealthHub stores and telehealth services continuing on schedule amidst the pandemic. Walgreens has lagged behind CVS in its plans to add healthcare clinics to its retail stores. CVS's relationship with UPS may prove an additional tailwind amidst the pandemic. Walgreens partners with UPS's smaller competitor, FedEx.
NYSE:CVSLong
by ChristopherCarrollSmith